Takafumi Mie Selected Research

Takafumi Mie Research Topics

Disease

25	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 05/2020
6	Neoplasms (Cancer) 04/2024 - 04/2021
3	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2021
3	Pathologic Constriction (Stenosis) 04/2024 - 12/2020
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2024 - 01/2023
3	Cholangitis 01/2023 - 11/2020
2	Pancreatitis 04/2024 - 11/2020
2	Rupture 04/2024 - 12/2020
2	False Aneurysm (Pseudoaneurysm) 04/2024 - 10/2023
2	Hemobilia 04/2024 - 07/2021
2	Hemorrhage 03/2024 - 12/2020
2	Cachexia 07/2023 - 07/2021
2	Duodenal Obstruction 01/2023 - 01/2023
2	Sarcopenia 07/2021 - 04/2021
2	Anorexia 04/2021 - 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 05/2024
1	Obstructive Jaundice (Cholestatic Jaundice) 04/2024
1	Jaundice (Icterus) 04/2024
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024
1	Microsatellite Instability 02/2024
1	Fever (Fevers) 10/2023
1	Shock 10/2023
1	Body Weight (Weight, Body) 07/2023
1	Weight Loss (Weight Reduction) 07/2023
1	Diabetes Mellitus 07/2023
1	Stroke (Strokes) 04/2023
1	Hyperplasia 01/2023
1	COVID-19 12/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2022
1	Carcinogenesis 01/2022
1	Turcot syndrome 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Adenocarcinoma 10/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 10/2021
1	Enteritis 10/2021
1	Neutropenia 07/2021
1	Disease Progression 07/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021
1	Diarrhea 01/2021
1	Klatskin Tumor 12/2020
1	Cholecystitis 11/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019

Drug/Important Bio-Agent (IBA)

14	Gemcitabine FDA Link 04/2023 - 05/2020
12	130-nm albumin-bound paclitaxelIBA 04/2023 - 05/2020
11	folfirinoxIBA 03/2024 - 05/2020
4	MetalsIBA 04/2024 - 01/2023
2	Leucovorin (Folinic Acid)FDA Link 12/2022 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 01/2021
1	IceIBA 03/2024
1	TropomyosinIBA 02/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2024
1	Poly Adenosine Diphosphate RiboseIBA 02/2024
1	Phosphotransferases (Kinase)IBA 02/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2024
1	human ERBB2 proteinIBA 02/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2024
1	EnzymesIBA 10/2023
1	anamorelinIBA 07/2023
1	Ghrelin ReceptorsIBA 07/2023
1	CarbohydratesIBA 11/2022
1	AntigensIBA 11/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Bendamustine Hydrochloride FDA Link 12/2021
1	obinutuzumabIBA 12/2021
1	UracilIBA 10/2021
1	dihydrouracilIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2019

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 05/2024 - 12/2020
11	Stents 04/2024 - 11/2020
7	Self Expandable Metallic Stents 04/2024 - 11/2020
6	Therapeutics 02/2024 - 01/2019
4	Neoadjuvant Therapy 04/2024 - 11/2020
1	Palliative Care (Palliative Therapy) 04/2024
1	Pancreaticoduodenectomy 04/2024
1	Radiotherapy 03/2024
1	Sphincterotomy 03/2024
1	Precision Medicine 02/2024
1	Surgical Instruments (Clip) 04/2023
1	Terminal Care (Care, Terminal) 12/2022
1	Pancreatectomy 09/2022
1	Adjuvant Chemotherapy 05/2022
1	Catheters 06/2021
1	Treatment Delay 04/2021
1	Sclerotherapy 12/2020